February 2016 – Page 3 – Policy & Medicine

Biosimilars Clinical Studies and Analytical Similarity Summit – Update on Biosimilars

Electronic Health Records and the Meaningful Use Program: Is the End Near?

Life Science Compliance Update, February 2016: Technology and Compliance

Testy Oversight and Government Reform Committee Hearing on Prescription Drug Pricing

Physician Payment Sunshine Act: Open Payments Final 2015 Data Submission and Attestation Help

Open Payments Question & Answer Session on February 9, 2016

ICMEJ Proposes Data Socialism – Data Utopianism Has its Cracks – Comments Due April 18

European Medicines Agency: Framework for Interaction with Industry

DOJ Becoming Comfortable With Permitting Truthful, Non-misleading Promotion